We are live on ! Find out more
KURA icon

Kura Oncology
KURA

171 hedge funds and large institutions have $1.94B invested in Kura Oncology in 2021 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 70 increasing their positions, 55 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,713% more call options, than puts

Call options by funds: $17M | Put options by funds: $446K

40% more funds holding in top 10

Funds holding in top 10: 5 → 7 (+2)

27% more repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 55

3.23% more ownership

Funds ownership: 100.36% → 103.59% (+3.2%)

9% less capital invested

Capital invested by funds: $2.12B → $1.94B (-$183M)

14% less funds holding

Funds holding: 198 → 171 (-27)

68% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 37

Holders
171
Holders Change
-27
Holders Change %
-13.64%
% of All Funds
3%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.12%
New
12
Increased
70
Reduced
55
Closed
37
Calls
$17M
Puts
$446K
Net Calls
+$16.6M
Net Calls Change
-$394K

Top Buyers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
+$60.7M
2
Ameriprise
Ameriprise
Minnesota
+$44.8M
3
Invesco
Invesco
Georgia
+$44.7M
4
Holocene Advisors
Holocene Advisors
New York
+$19.7M
5
EAM
Eventide Asset Management
Massachusetts
+$17.6M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$51.6M
2
CAM
Cormorant Asset Management
Massachusetts
-$21.2M
3
RI
RTW Investments
New York
-$19.6M
4
CS
Credit Suisse
Switzerland
-$19M
5
N
Nuveen
North Carolina
-$14M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$20.3M -$1.1M -34,850 -5%
RSCM
27
Rock Springs Capital Management
Maryland
$20.1M +$6.39M +201,919 +40%
HA
28
HHLR Advisors
Cayman Islands
$18.4M – – –
Two Sigma Advisers
29
Two Sigma Advisers
New York
$17.9M +$4.33M +137,000 +28%
Two Sigma Investments
30
Two Sigma Investments
New York
$17.2M +$771K +24,367 +4%
AG
31
Artal Group
Luxembourg
$17M – – –
GTC
32
Ghost Tree Capital
New York
$17M +$8.7M +275,000 +85%
VA
33
VR Adviser
New York
$16.3M – – –
ACP
34
Acuta Capital Partners
California
$15.2M -$3.19M -100,680 -16%
VC
35
Vivo Capital
California
$14.8M – – –
CC
36
Commodore Capital
New York
$14.7M +$12.3M +388,052 +291%
Charles Schwab
37
Charles Schwab
California
$12.5M +$683K +21,588 +5%
FCM
38
Farallon Capital Management
California
$11.3M +$8.7M +275,000 +220%
AAA
39
Affinity Asset Advisors
New York
$10.3M +$3.32M +105,000 +40%
PCH
40
Polar Capital Holdings
United Kingdom
$9.89M +$3.45M +109,000 +45%
D.E. Shaw & Co
41
D.E. Shaw & Co
New York
$9.81M -$7.38M -233,403 -40%
Millennium Management
42
Millennium Management
New York
$9.19M +$3.71M +117,192 +56%
UBS AM
43
UBS AM
Illinois
$8.48M +$1.29M +40,660 +16%
Bank of New York Mellon
44
Bank of New York Mellon
New York
$8.43M +$403K +12,746 +4%
N
45
Nuveen
North Carolina
$8.2M -$14M -441,950 -60%
ACM
46
Asymmetry Capital Management
California
$7.84M -$2.18M -69,050 -20%
TCM
47
Tekla Capital Management
Massachusetts
$7.73M – – –
SCM
48
Sio Capital Management
New York
$6.04M +$2.57M +81,188 +61%
Verition Fund Management
49
Verition Fund Management
Connecticut
$5.51M +$1.64M +51,788 +36%
Axa
50
Axa
France
$4.99M +$103K +3,270 +2%
1
2
3 4 5

KURA Hedge Fund Activity: Q1 2021 in Review

171 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q1 2021, worth a combined $1.94B — down 8.6% from $2.12B a quarter earlier.

Sellers outnumbered buyers: 37 funds closed out of KURA and 12 opened new positions — a net loss of 25 holders — while 55 trimmed existing stakes and 70 added.

The largest buyer was EcoR1 Capital, adding an estimated $60.7M. The largest seller was Citadel Advisors, cutting an estimated $51.6M.

  • 171 institutional investors held Kura Oncology (KURA) as of Q1 2021, down from 198 in Q4 2020.
  • Funds reported $1.94B of Kura Oncology stock for Q1 2021, down 8.6% quarter-over-quarter.
  • 12 funds opened new Kura Oncology positions in Q1 2021 and 37 closed out, a net change of -25 holders.
  • The largest Kura Oncology buyer in Q1 2021 was EcoR1 Capital, an estimated $60.7M added.
  • The largest Kura Oncology seller in Q1 2021 was Citadel Advisors, an estimated $51.6M sold.

Based on aggregated 13F filings for Q1 2021.